Keebeck Wealth Management purchased a new stake in Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,809 shares of the company’s stock, valued at approximately $608,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of PLMR. BlackRock Inc. purchased a new stake in Palomar during the 2nd quarter worth approximately $556,348,000. Vanguard Group Inc. grew its position in shares of Palomar by 2.5% during the fourth quarter. Vanguard Group Inc. now owns 2,698,278 shares of the company’s stock worth $363,620,000 after buying an additional 67,038 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of Palomar by 17.4% during the first quarter. Janus Henderson Group PLC now owns 933,993 shares of the company’s stock worth $111,664,000 after buying an additional 138,368 shares in the last quarter. Westfield Capital Management Co. LP grew its position in shares of Palomar by 13.8% during the fourth quarter. Westfield Capital Management Co. LP now owns 840,226 shares of the company’s stock worth $113,229,000 after buying an additional 101,698 shares in the last quarter. Finally, Stephens Investment Management Group LLC increased its stake in shares of Palomar by 3.0% in the first quarter. Stephens Investment Management Group LLC now owns 714,914 shares of the company’s stock worth $85,432,000 after buying an additional 20,597 shares during the last quarter. Hedge funds and other institutional investors own 90.25% of the company’s stock.
Palomar Price Performance
Shares of NASDAQ PLMR opened at $130.09 on Friday. The company has a current ratio of 0.50, a quick ratio of 0.50 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $3.42 billion, a price-to-earnings ratio of 17.49 and a beta of 0.40. Palomar Holdings, Inc. has a twelve month low of $100.81 and a twelve month high of $147.62. The business has a 50 day simple moving average of $130.76 and a 200-day simple moving average of $123.92.
Palomar Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 2nd. Stockholders of record on Wednesday, August 19th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, August 19th. Palomar’s dividend payout ratio (DPR) is presently 24.19%.
Key Stories Impacting Palomar
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Strong premium growth and expansion in specialty insurance are expected to support Palomar’s earnings momentum. Analysts’ average price target of $162.75 and recent target increases reinforce the bullish view. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
- Positive Sentiment: Dowling & Partners expressed a positive view of Palomar’s fiscal 2026 earnings outlook, adding to expectations for continued profit growth. DOWLING & PARTN Has Positive View of Palomar FY2026 Earnings
- Positive Sentiment: Palomar’s latest quarterly results provide fundamental support: earnings per share of $2.36 exceeded the $2.19 consensus estimate, while profitability and return on equity remained strong.
- Neutral Sentiment: Several insiders, including the president, CFO and Jonathan Knutzen, sold relatively small portions of their holdings to cover tax withholding on vested equity awards. Because the transactions were not discretionary sales, they are less negative than typical insider selling, though they may limit near-term sentiment.
- Neutral Sentiment: Palomar declared a quarterly dividend of $0.45, equivalent to $1.80 annually and a yield of approximately 1.4%, providing modest shareholder support.
- Negative Sentiment: Competitive pricing could reduce premium profitability, while a higher combined ratio would pressure underwriting margins. These risks may temper the market’s response to otherwise strong growth expectations. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
Analyst Ratings Changes
PLMR has been the topic of several recent analyst reports. Weiss Ratings raised shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, June 18th. Zacks Research lowered shares of Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Piper Sandler boosted their target price on shares of Palomar from $132.00 to $165.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 15th. JPMorgan Chase & Co. upped their target price on shares of Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research note on Monday, July 20th. Finally, Keefe, Bruyette & Woods increased their price target on shares of Palomar from $166.00 to $167.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $162.75.
View Our Latest Stock Report on PLMR
Insider Buying and Selling
In related news, CFO T Christopher Uchida sold 791 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $127.74, for a total transaction of $101,042.34. Following the completion of the sale, the chief financial officer owned 16,238 shares of the company’s stock, valued at $2,074,242.12. This represents a 4.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Rodolphe Herve sold 1,207 shares of the stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $135.35, for a total transaction of $163,367.45. Following the sale, the chief operating officer owned 3,548 shares in the company, valued at approximately $480,221.80. This trade represents a 25.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 20,165 shares of company stock worth $2,680,993. Company insiders own 3.70% of the company’s stock.
Palomar Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Read More
- Five stocks we like better than Palomar
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
